Labshake search
Citations for Invivogen :
401 - 450 of 1573 citations for 4 Fluoro 5 1 pyrazolyl 2 nitrobenzoic acid since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2024Quote: ... HeLa cells were selected with 5 μg/ml blasticidin (Invivogen) and 200 μg/ml zeocin (Invivogen).
-
bioRxiv - Cancer Biology 2024Quote: ... and 5 ug/ml plasmocin prophylactic (Invivogen, San Diego, CA). Plates were incubated at 37°C with 5% CO2 until cells were approximately 80% confluent ...
-
bioRxiv - Microbiology 2024Quote: ... and 50 µg/mL hygromycin B (InvivoGen #ant-hg-5) at 26 °C ...
-
bioRxiv - Immunology 2023Quote: ... cells were transferred to selective medium containing 4 µg/mL Blasticidin (Invivogen) (MC38-B2m-/- transduced with Her2/neu ...
-
bioRxiv - Systems Biology 2023Quote: ... TLR4 agonist at 4 ng/mL (LPS-B5, Invivogen, San Diego, CA), BTC at 40 ng/mL (human recombinant Betacellulin protein ...
-
bioRxiv - Immunology 2024Quote: ... and BA.4/5 variants harboring GFP and luciferase reporter genes was performed as previously described for the WT PSV.43 Plasmids carrying the full-length SARS-CoV-2 spike protein from each variant containing a C-terminal 19 amino acid deletion to remove the ER retention signal were used for pseudotyping (Invivogen). Viral titers (TU/mL ...
-
bioRxiv - Molecular Biology 2020Quote: ... Puromycin (InVivoGen, Cat#ant-pr; CAS: 58-58-2) was added in the culture medium (1µM ...
-
bioRxiv - Cancer Biology 2021Quote: ... Cells were selected by puromycin (2 μg/ml) (InvivoGen) 3 days postelectroporation ...
-
bioRxiv - Immunology 2020Quote: ... Pam3CSK4 (TLR1/2; tlrl-pms; Invivogen, 200 ng/ml), Poly (I:C ...
-
bioRxiv - Molecular Biology 2022Quote: ... 100 ug/ml Primocin (Invivogen, Cat# ant-pm-2), 10 mM nicotinamide (Sigma ...
-
bioRxiv - Cell Biology 2020Quote: ... 35% BSA and 2 ug/mL Plasmocin (InvivoGen, USA). Cells were cultivated for 30 days under the described conditions before passaging as single cells to specific experiments.
-
bioRxiv - Bioengineering 2020Quote: ... supplemented with the antibiotic primocin (Invivogen, ant-pm-2) in a concentration of 1 ...
-
bioRxiv - Cell Biology 2020Quote: ... Cells were selected using 2 μg/mL puromycin (InvivoGen).
-
bioRxiv - Immunology 2020Quote: ... 2 μg/ml of C3-YSD (InvivoGen, tlrl-ydnac), or 25 pmol of ISD (IDT ...
-
bioRxiv - Cancer Biology 2022Quote: ... 100 μg/ml Primocin (Invivogen, Cat#ant-pm-2), and 10 μM Y27632 (AbMole ...
-
bioRxiv - Immunology 2022Quote: ... and 50mg/ml Normocin (InvivoGen cat. # ant-nr-2).
-
bioRxiv - Immunology 2023Quote: ... and alhydrogel adjuvant 2% (alum, InvivoGen, vac-alu-250)) or alhydrogel adjuvant alone in a ratio of 1:1 (v/v) ...
-
bioRxiv - Cancer Biology 2024Quote: ... and Primocin (100 μg/ml, InvivoGen, ant-pm-2). WENR is ENR medium supplemented with 5 nM Wnt-surrogate (Life Technologies ...
-
bioRxiv - Genetics 2023Quote: ... with 100 μg/ml primocin (Invivogen, ant-pm-2), 10% BIT 9500 (Stemcell Technologies 09500) ...
-
bioRxiv - Cell Biology 2023Quote: ... and 50 μg/ml Primocin (InvivoGen #ant-pm-2). For culturing human ASPCs ...
-
bioRxiv - Immunology 2024Quote: ... 2) 0.2 ng/µL LPS-R (tlrl-eklps; Invivogen) as a positive control for human TLR4 ...
-
bioRxiv - Immunology 2024Quote: ... BX795 (100 ng/ml, InvivoGen, catalog tlrl-bx7-2) for 1 hour and then infected with either B ...
-
bioRxiv - Cell Biology 2024Quote: ... 100 µg/mL Primocin (Cat#ant-pm-2, InvivoGen), 1 µM ALK5 inhibitor A83-01 (Cat#2939/10 ...
-
bioRxiv - Immunology 2021Quote: ... at 5 μg/mL or the TLR4 agonist lipopolysaccharide (LPS; Invivogen) at 100 ng/mL or the TLR9 agonist class A CpG ODNs (CpG-A ...
-
bioRxiv - Immunology 2020Quote: ... and for TLR9 stimulation 5 µg/ml ODN1826 (tlrl-1826, InvivoGen). Unstimulated DC received no additives ...
-
bioRxiv - Microbiology 2022Quote: ... Transfectants were selected with 5 μg/mL hygromycin B Gold (Invivogen). RNAi was induced with 1 μg/mL tetracycline (Sigma).
-
bioRxiv - Immunology 2022Quote: ... and stimulated with 2.5 μg/mL R848 (Invivogen, tlrl-r848-5) and 1,000 U/mL human recombinant IL-2 (ImmunoTools ...
-
bioRxiv - Biochemistry 2023Quote: ... Cells were selected under either 5 μg/ml Blasticidin-S (Invivogen) for two weeks or 5 μg/ml Puromycin (Invivogen ...
-
bioRxiv - Neuroscience 2023Quote: ... with addition of 100 μg/mL G418 (Invivogen, #ant-gn-5) in case of GL261-tdTomato+Luc+ cells ...
-
bioRxiv - Molecular Biology 2023Quote: ... Recombined cells were selected with 5 μg/mL blasticidin S (InvivoGen) and 250 μg/mL hygromycin B (Roche Diagnostics ...
-
bioRxiv - Cancer Biology 2023Quote: ... or with 5 ug/ml OVA peptide (a.a.257-264, InvivoGen) for 4-5 hr in the presence of Golgi Stop (1/1000 ...
-
bioRxiv - Molecular Biology 2023Quote: ... and selected with 5 μg/ml blasticidin (Invivogen, ant-bl-10p). Subsequently ...
-
bioRxiv - Immunology 2023Quote: ... and RIG-I agonist (5’ triphosphate hairpin RNA, 3p-hpRNA, Invivogen). CHME-5xISRE-Nluc cells were maintained in DMEM supplemented with 10% FBS and pen/strep with 0.1 mg/ml hygromycin ...
-
The HUSH epigenetic repressor complex silences PML nuclear bodies-associated HSV-1 quiescent genomesbioRxiv - Microbiology 2024Quote: ... Stable transfectants were selected with Blasticidin S (5 μg/mL, Invivogen), puromycin (1 μg/mL ...
-
bioRxiv - Cancer Biology 2021Quote: ... 6-8 weeks old CM knock-in mice were injected intraperitoneally with polyinosinic–polycytidylic acid [poly (I:C)] (InvivoGen, tlrl-picw-250) at 14 mg/kg/dose every other day for a total of 7 doses ...
-
bioRxiv - Cancer Biology 2024Quote: ... or 10 mg/kg anti-CTLA-4 (clone 9D9, cat. mctla4-mab10, InvivoGen). Antibodies were administered twice weekly for a maximum of four weeks.
-
bioRxiv - Microbiology 2022Quote: ... of recombinant viruses or purified SARS-CoV-2 spike protein adjuvanted with aluminum hydroxide (alum, 2% alhydrogel adjuvant, Cat# vac-alu-250, InvivoGen, San Diego, CA, USA). A prime-boost vaccination regimen was used ...
-
bioRxiv - Immunology 2021Quote: ... Transfected cells were selected with 2 µg/ml puromycin (InvivoGen) until death of non-transfected control.
-
bioRxiv - Microbiology 2021Quote: ... and mixed 50 % v/v with alhydrogel adjuvant 2 % (InvivoGen) for two hours at room temperature ...
-
bioRxiv - Cancer Biology 2022Quote: ... containing 100 μg/ml Primocin (Invivogen, Cat#ant-pm-2) and 10 ml/L Penicillin-Streptomycin (Sigma ...
-
bioRxiv - Molecular Biology 2022Quote: ... U2OS cells were selected under 2 μg/ml puromycin (Invivogen) for 3 days.
-
bioRxiv - Neuroscience 2024Quote: ... supplemented with Primocin (0.1 μg/ml; Invivogen; ANT-PM-2) on Geltrex-coated (Gibco ...
-
bioRxiv - Neuroscience 2023Quote: ... supplemented with primocin (0.1 μg/ml, Invivogen, #ant-pm-2). For quality check ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... supplemented with 0.5 mg/mL normocin (InvivoGen, ant-nr-2). Cultures were tested for mycoplasma every 30 days.
-
bioRxiv - Bioengineering 2023Quote: ... and Alum (Alhydrogel 2%; vac-alu) were purchased from Invivogen. 3M-052 and 3M-052/Alum (AAHI-AL030 ...
-
bioRxiv - Microbiology 2023Quote: ... and 100 mg/mL of normocin (InvivoGen, #ant-nr-2), and grown in cell culture flasks at 30 °C in a humidified incubator containing 5% CO2 ...
-
bioRxiv - Neuroscience 2023Quote: ... supplemented with 0.1 mg/mL Primocin (Invivogen, ant-pm-2) on 6-well plates pre-coated with Matrigel (1:15 diluted in DMEM/F12 medium ...
-
bioRxiv - Cell Biology 2023Quote: ... + 2% Ultroser G (Cytogen, Germany) and 0.2% primocin (InvivoGen, USA). The alveolar cells were grown and differentiated under ALI conditions in AEpiCM-Alveolar Epithelial Cell Medium (ScienCell ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 50 mg/mL Normicin (Invivogen, Cat# ant-nr-2) and maintained in a 37°C humidified incubator with 5% CO2.
-
bioRxiv - Microbiology 2023Quote: ... and 100 mg/mL of normocin (InvivoGen, #ant-nr-2) and grown in cell culture flasks at 37 °C in a humidified incubator containing 5% CO2 ...